Accuray Incorporated (NASDAQ:ARAY) is a favorite amongst institutional investors who own 64%
Key Insights Institutions' substantial holdings in Accuray implies that they have significant influence over the...
Stay updated with breaking news from Accuray. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Key Insights Institutions' substantial holdings in Accuray implies that they have significant influence over the...
StockNews.com lowered shares of Accuray (NASDAQ:ARAY – Free Report) from a buy rating to a hold rating in a research note released on Wednesday. Separately, TheStreet raised Accuray from a d+ rating to a c- rating in a research report on Monday, June 5th. Check Out Our Latest Stock Report on ARAY Accuray Stock Down […]
Accuray (NASDAQ:ARAY – Get Free Report) posted its earnings results on Wednesday. The medical equipment provider reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.01 by ($0.04), RTT News reports. Accuray had a negative net margin of 2.32% and a negative return on equity of 19.56%. The business had revenue of $118.29 […]
The CyberKnife S7 by Accuray is an advanced robotic radiotherapy system in cancer treatment. This cutting-edge technology is designed to deliver highly precise and non-invasive radiation therapy to target tumours.
Foundry Partners LLC raised its holdings in Accuray Incorporated (NASDAQ:ARAY – Free Report) by 10.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,737,427 shares of the medical equipment provider’s stock after purchasing an additional 161,980 shares during the period. Foundry […]